BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34867089)

  • 1. Uncovering a Key Role of ETS1 on Vascular Abnormality in Glioblastoma.
    Tang J; Li Y; Liu B; Liang W; Hu S; Shi M; Zeng J; Li M; Huang M
    Pathol Oncol Res; 2021; 27():1609997. PubMed ID: 34867089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma.
    Huang M; Liu T; Ma P; Mitteer RA; Zhang Z; Kim HJ; Yeo E; Zhang D; Cai P; Li C; Zhang L; Zhao B; Roccograndi L; O'Rourke DM; Dahmane N; Gong Y; Koumenis C; Fan Y
    J Clin Invest; 2016 May; 126(5):1801-14. PubMed ID: 27043280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
    Chang HH; Cheng YC; Tsai WC; Chen Y
    Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells.
    Koessinger D; Albrecht V; Faber F; Jaehnert I; Schichor C
    Anticancer Res; 2018 Jun; 38(6):3347-3355. PubMed ID: 29848683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
    Bhattacharya R; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells.
    Wang H; Shi Y; Zhou X; Zhang L; Yang A; Zhou D; Ma T
    Cell Biol Toxicol; 2024 Jun; 40(1):44. PubMed ID: 38862832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
    J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
    Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W
    Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
    Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
    Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
    Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
    Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
    Nana AW; Yang PM; Lin HY
    Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.
    Qu M; Yu J; Liu H; Ren Y; Ma C; Bu X; Lan Q
    Mol Cells; 2017 Oct; 40(10):761-772. PubMed ID: 29047259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type-1 domain-containing 7A in glioblastoma.
    Oishi M; Munesue S; Harashima A; Nakada M; Yamamoto Y; Hayashi Y
    Cancer Med; 2020 Jun; 9(11):3904-3917. PubMed ID: 32253832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.
    Smits M; Nilsson J; Mir SE; van der Stoop PM; Hulleman E; Niers JM; de Witt Hamer PC; Marquez VE; Cloos J; Krichevsky AM; Noske DP; Tannous BA; Würdinger T
    Oncotarget; 2010 Dec; 1(8):710-20. PubMed ID: 21321380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of microRNA-16 in Glioblastoma Inhibits the Function of Endothelial Cells and Tumor Angiogenesis by Targeting Bmi-1.
    Chen F; Chen L; He H; Huang W; Zhang R; Li P; Meng Y; Jiang X
    Anticancer Agents Med Chem; 2016; 16(5):609-20. PubMed ID: 26373393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin Controls Angiogenesis-Dependent Glioblastoma Growth.
    Frisch A; Kälin S; Monk R; Radke J; Heppner FL; Kälin RE
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircPITX1 Regulates Proliferation, Angiogenesis, Migration, Invasion, and Cell Cycle of Human Glioblastoma Cells by Targeting miR-584-5p/KPNB1 Axis.
    Cao Y; Wang F; Chen Y; Wang Y; Song H; Long J
    J Mol Neurosci; 2021 Aug; 71(8):1683-1695. PubMed ID: 33763840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma.
    Sharma I; Singh A; Siraj F; Saxena S
    J Biomed Sci; 2018 Aug; 25(1):62. PubMed ID: 30086759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma.
    Ke C; Luo JR; Cen ZW; Li Y; Cai HP; Wang J; Chen FR; Siegel ER; Le KN; Winokan JR; Gibson GJ; McSwain AE; Afrasiabi K; Linskey ME; Zhou YX; Chen ZP; Zhou YH
    Cancer Sci; 2020 Mar; 111(3):940-950. PubMed ID: 31922633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.